The interactions between the nervous and immune systems have been recognize
d in the development of neurodegenerative disease. This can be exploited th
rough detection of the immune response to autoantigens in assessing the neu
rotoxicity of environmental chemicals. To test this hypothesis. the followi
ng questions were addressed. a) Are autoantibodies to nervous system (NS) a
ntigens detected in populations exposed to environmental or occupational ch
emicals? In sera of male workers exposed to lead or mercury, autoantibodies
, primarily IgG. to neuronal cytoskeletal proteins, neurofilaments (NFs). a
nd myelin basic protein (MBP) were prevalent. These findings were confirmed
in mice and rats exposed to either metal. b) Do autoantibodies to NS antig
ens relate to indices of exposure? In humans exposed to either metal, and s
imilarly in exposed rats, titers of IgG against NFs and MBP significantly c
orrelated with blood lead or urinary mercury the typical indices of exposur
e. c) Do autoantibodies correlate with sensorimotor deficits? In workers ex
posed to lead or mercury, a significant correlation was observed between Ig
G titers and subclinical deficits. Doses of metals used in rat exposures we
re subclinical. suggesting that autoantibodies may be predictive of neuroto
xicity. d) Is the detection indicative of nervous system pathology? In rats
exposed to metals, histopathology indicated central nervous system (CNS) a
nd peripheral nervous system (PNS) damage. In addition there was evidence o
f astrogliosis, which is indicative of neuronal damage in the CNS. and the
presence of IgG concentrated along the blood-brain barrier, as indicated by
immunostaining for antibodies. e) Are immune responses to NS antigens path
ogenic? Immunoglobulin fractions from rat and human sera interfered with ne
uromuscular function. These studies suggest that the detection of autoantib
odies to NS-specific antigens may be used to monitor the development of neu
rotoxicity to environmental chemicals and that immune mechanisms may be inv
olved in the progression of neurodegeneration.